This was my latest column for the Free Lance-Star on Sunday June 27th. The FDA’s approval of a new drug to treat Alzheimer’s Disease has prompted a lot of hope. But also prompted three members of the FDA’s advisory committee to resign. Will the New Medicine Stop This? Aducanumab, marketed by Biogen and Eisai by…
Read more
From Emergency to Common Sense Healthcare.
Never coy about running my mouth, and as someone involved in providing primary care to an underserved community through the Moss Clinic, I was pleased to be asked to participate in a panel discussion of problems with primary care access in “the time of COVID.” More Than Just Picking Up Trainwrecks A discussion that introduced…
Read more